Inulin-type fructan improves diabetic phenotype and gut microbiota profiles in rats

PeerJ

Volumn 2018, Issue 3, 2018, Pages

  Zhang, Qian ^a   Yu, Hongyue ^b   Xiao, Xinhua ^a   Hu, Ling ^b   Xin, Fengjiao ^c   Yu, Xiaobing ^d  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^c INSTITUTE OF PLANT PROTECTION   (China)

^d Fengning Ping'an High tech Industrial Co   (China)

Author keywords

Diabetes; Gut microbiota; Inulin; Soluble fiber

Indexed keywords

FRUCTAN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; INTERLEUKIN 6; INULIN; LIPOPOLYSACCHARIDE; RNA 16S; SHORT CHAIN FATTY ACID; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BACTEROIDETES; BODY WEIGHT; CONTROLLED STUDY; DESULFOVIBRIO; DIABETES MELLITUS; DNA EXTRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIRMICUTES; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INTESTINE FLORA; LACHNOSPIRACEAE; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; POPULATION ABUNDANCE; PROTEIN EXPRESSION; PYROSEQUENCING; RAT;

EID: 85042708007     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.4446     Document Type: Article

References (66)

1. Adser H, Wojtaszewski JF, Jakobsen AH, Kiilerich K, Hidalgo J, Pilegaard H. 2011. Interleukin-6 modifies mRNA expression in mouse skeletal muscle. Acta Physiologica 202:165-173 DOI 10.1111/j.1748-1716.2011.02269.x
2. Alles MS, Hautvast JG, Nagengast FM, Hartemink R, Van Laere KM, Jansen JB. 1996. Fate of fructo-oligosaccharides in the human intestine. British Journal of Nutrition 76:211-221 DOI 10.1079/BJN19960026
3. Banzet S, Koulmann N, Simler N, Sanchez H, Chapot R, Serrurier B, Peinnequin A, Bigard X. 2009. Control of gluconeogenic genes during intense/prolonged exercise: hormone-independent effect of muscle-derived IL-6 on hepatic tissue and PEPCK mRNA. Journal of Applied Physiology 107:1830-1839 DOI 10.1152/japplphysiol.00739.2009
4. Baothman OA, Zamzami MA, Taher I, Abubaker J, Abu-Farha M. 2016. The role of gut Microbiota in the development of obesity and diabetes. Lipids in Health and Disease 15:Article 108 DOI 10.1186/s12944-016-0278-4
5. Beerens H, Romond C. 1977. Sulfate-reducing anaerobic bacteria in human feces. American Journal of Clinical Nutrition 30:1770-1776 DOI 10.1093/ajcn/30.11.1770
6. Bellahcene M, O'Dowd JF, Wargent ET, Zaibi MS, Hislop DC, Ngala RA, Smith DM, Cawthorne MA, Stocker CJ, Arch JR. 2013. Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat con-tent. British Journal of Nutrition 109:1755-1764 DOI 10.1017/S0007114512003923
7. Buldak L, Machnik G, Buldak RJ, Labuzek K, Boldys A, Belowski D, Basiak M, Okopien B. 2016. Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner. Pharmacological Reports 68:329-337 DOI 10.1016/j.pharep.2015.10.008
8. Busserolles J, Gueux E, Rock E, Demigne C, Mazur A, Rayssiguier Y. 2003. Oligofruc-tose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats. Journal of Nutrition 133:1903-1908 DOI 10.1093/jn/133.6.1903
9. Campbell JM, Fahey Jr GC, Wolf BW. 1997. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. Journal of Nutrition 127:130-136
10. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470-1481 DOI 10.2337/db07-1403
11. Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon G, Delzenne NM. 2005a. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. Journal of Endocrinol-ogy 185:457-465 DOI 10.1677/joe.1.06100
12. Cani PD, Joly E, Horsmans Y, Delzenne NM. 2006a. Oligofructose promotes satiety in healthy human: a pilot study. European Journal of Clinical Nutrition 60:567-572 DOI 10.1038/sj.ejcn.1602350
13. Cani PD, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R. 2006b. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55:1484-1490 DOI 10.2337/db05-1360
14. Cani PD, Neyrinck AM, Maton N, Delzenne NM. 2005b. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obesity Research 13:1000-1007 DOI 10.1038/oby.2005.117
15. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. 2010. QIIME allows analysis of high-throughput community sequencing data. Nature Methods 7:335-336 DOI 10.1038/nmeth.f.303
16. Chang CJ, Lin CS, Lu CC, Martel J, Ko YF, Ojcius DM, Tseng SF, Wu TR, Chen YY, Young JD, Lai HC. 2015. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nature Communications 6:Article 7489 DOI 10.1038/ncomms8489
17. Chen G, Yang X, Yang X, Li L, Luo J, Dong H, Xu L, Yi P, Wang K, Zou X, Lu F. 2017. Jia-Wei-Jiao-Tai-Wan ameliorates type 2 diabetes by improving beta cell function and reducing insulin resistance in diabetic rats. BMC Complementary and Alternative Medicine 17:Article 507 DOI 10.1186/s12906-017-2016-5
18. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P, Andersen GL. 2006. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Applied and Environmental Micro-biology 72:5069-5072 DOI 10.1128/AEM.03006-05
19. Edgar RC. 2013. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nature Methods 10:996-998 DOI 10.1038/nmeth.2604
20. Estaki M, Pither J, Baumeister P, Little JP, Gill SK, Ghosh S, Ahmadi-Vand Z, Mars-den KR, Gibson DL. 2016. Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functions. Microbiome 4:Article 42 DOI 10.1186/s40168-016-0189-7
21. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J. 2009. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58:1509-1517 DOI 10.2337/db08-1637
22. Garcia-Mazcorro JF, Ivanov I, Mills DA, Noratto G. 2016. Influence of whole-wheat consumption on fecal microbial community structure of obese diabetic mice. PeerJ 4:e1702 DOI 10.7717/peerj.1702
23. Guess ND, Dornhorst A, Oliver N, Frost GS. 2016. A randomised crossover trial: the effect of inulin on glucose homeostasis in subtypes of prediabetes. Annals of Nutrition and Metabolism 68:26-34 DOI 10.1159/000441626
24. Guo C, Huang T, Chen A, Chen X, Wang L, Shen F, Gu X. 2016. Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages. Brazilian Journal of Medical and Biological Research 49:e5826 DOI 10.1590/1414-431x20165826
25. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, Knight R, Ahima RS, Bushman F, Wu GD. 2009. High-fat diet determines the com-position of the murine gut microbiome independently of obesity. Gastroenterology 137:1716-1724 DOI 10.1053/j.gastro.2009.08.042
26. Huang WC, Lin CL, Hsu YJ, Chiu YS, Chen YM, Wu MF, Huang CC, Wang MF. 2016. Inulin and fibersol-2 combined have hypolipidemic effects on high cholesterol diet-induced hyperlipidemia in hamsters. Molecules 21:Article 313 DOI 10.3390/molecules21030313
27. Jung MJ, Lee J, Shin NR, Kim MS, Hyun DW, Yun JH, Kim PS, Whon TW, Bae JW. 2016. Chronic repression of mTOR complex 2 induces changes in the gut microbiota of diet-induced obese mice. Scientific Reports 6:30887 DOI 10.1038/srep30887
28. Kitano Y, Murazumi K, Duan J, Kurose K, Kobayashi S, Sugawara T, Hirata T. 2012. Effect of dietary porphyran from the red alga, Porphyra yezoensis, on glucose metabolism in diabetic KK-Ay mice. Journal of Nutritional Science and Vitaminology 58:14-19 DOI 10.3177/jnsv.58.14
29. Lam YY, Ha CW, Campbell CR, Mitchell AJ, Dinudom A, Oscarsson J, Cook DI, Hunt NH, Caterson ID, Holmes AJ, Storlien LH. 2012. Increased gut per-meability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLOS ONE 7:e34233 DOI 10.1371/journal.pone.0034233
30. Lau E, Marques C, Pestana D, Santoalha M, Carvalho D, Freitas P, Calhau C. 2016. The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity. Nutrition & Metabolism 13:Article 31 DOI 10.1186/s12986-016-0089-7
31. Lee YS, Park MS, Choung JS, Kim SS, Oh HH, Choi CS, Ha SY, Kang Y, Kim Y, Jun HS. 2012. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia 55:2456-2468 DOI 10.1007/s00125-012-2592-3
32. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America 102:11070-11075 DOI 10.1073/pnas.0504978102
33. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444:1022-1023 DOI 10.1038/4441022a
34. Liu F, Prabhakar M, Ju J, Long H, Zhou HW. 2017. Effect of inulin-type fructans on blood lipid profile and glucose level: a systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Nutrition 71:9-20 DOI 10.1038/ejcn.2016.156
35. Loubinoux J, Mory F, Pereira IA, Le Faou AE. 2000. Bacteremia caused by a strain of Desulfovibrio related to the provisionally named Desulfovibrio fairfieldensis. Journal of Clinical Microbiology 38:931-934
36. Lozupone C, Knight R. 2005. UniFrac: a new phylogenetic method for comparing microbial communities. Applied and Environmental Microbiology 71:8228-8235 DOI 10.1128/AEM.71.12.8228-8235.2005
37. Macfarlane GT, Macfarlane S. 1997. Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scandinavian Journal of Gastroenterol-ogy. Supplement 222:3-9 DOI 10.1080/00365521.1997.11720708
38. Magoc T, Salzberg SL. 2011. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27:2957-2963 DOI 10.1093/bioinformatics/btr507
39. Meier JJ, Nauck MA. 2005. Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes/Metabolism Research and Reviews 21:91-117 DOI 10.1002/dmrr.538
40. Murphy EF, Cotter PD, Healy S, Marques TM, O'Sullivan O, Fouhy F, Clarke SF, O'Toole PW, Quigley EM, Stanton C, Ross PR, O'Doherty RM, Shanahan F. 2010. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59:1635-1642 DOI 10.1136/gut.2010.215665
41. Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B. 2000. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. American Journal of Gastroenterology 95:1231-1238 DOI 10.1111/j.1572-0241.2000.02015.x
42. Ou JY, Huang JQ, Song Y, Yao SW, Peng XC, Wang MF, Ou SY. 2016. Feruloylated oligosaccharides from maize bran modulated the gut microbiota in rats. Plant Foods for Human Nutrition 71:123-128 DOI 10.1007/s11130-016-0547-4
43. Park J, Kim M, Kang SG, Jannasch AH, Cooper B, Patterson J, Kim CH. 2015. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol 8:80-93 DOI 10.1038/mi.2014.44
44. Pedersen L, Pilegaard H, Hansen J, Brandt C, Adser H, Hidalgo J, Olesen J, Pedersen BK, Hojman P. 2011. Exercise-induced liver chemokine CXCL-1 expression is linked to muscle-derived interleukin-6 expression. Journal de Physiologie 589:1409-1420 DOI 10.1113/jphysiol.2010.200733
45. Pendyala S, Walker JM, Holt PR. 2012. A high-fat diet is associated with en-dotoxemia that originates from the gut. Gastroenterology 142:1100-1101 DOI 10.1053/j.gastro.2012.01.034
46. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J. 2012. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55-60 DOI 10.1038/nature11450
47. Rabot S, Membrez M, Bruneau A, Gerard P, Harach T, Moser M, Raymond F, Man-sourian R, Chou CJ. 2010. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB Journal 24:4948-4959 DOI 10.1096/fj.10-164921
48. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. 2009. Effect of inulin on the human gut microbiota: stimulation of bifidobacterium adoles-centis and Faecalibacterium prausnitzii. British Journal of Nutrition 101:541-550 DOI 10.1017/S0007114508019880
49. Roshanravan N, Mahdavi R, Alizadeh E, Jafarabadi MA, Hedayati M, Ghavami A, Alipour S, Alamdari NM, Barati M, Ostadrahimi A. 2017. Effect of butyrate and inulin supplementation on glycemic status, lipid profile and glucagon-like peptide 1 level in patients with type 2 diabetes: a randomized double-blind, placebo-controlled trial. Hormone and Metabolic Research 49:886-891 DOI 10.1055/s-0043-119089
50. Scott KP, Martin JC, Duncan SH, Flint HJ. 2014. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiology Ecology 87:30-40 DOI 10.1111/1574-6941.12186
51. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. 2011. Metagenomic biomarker discovery and explanation. Genome Biology 12:Article R60 DOI 10.1186/gb-2011-12-6-r60
52. Stalin A, Irudayaraj SS, Gandhi GR, Balakrishna K, Ignacimuthu S, Al-Dhabi NA. 2016. Hypoglycemic activity of 6-bromoembelin and vilangin in high-fat diet fed-streptozotocin-induced type 2 diabetic rats and molecular docking studies. Life Sciences 153:100-117 DOI 10.1016/j.lfs.2016.04.016
53. Tai N, Wong FS, Wen L. 2015. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Reviews in Endocrine and Metabolic Disorders 16:55-65 DOI 10.1007/s11154-015-9309-0
54. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027-1031 DOI 10.1038/nature05414
55. Van de Wiele T, Boon N, Possemiers S, Jacobs H, Verstraete W. 2007. Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. Journal of Applied Microbiology 102:452-460 DOI 10.1111/j.1365-2672.2006.03084.x
56. Wang Q, Garrity GM, Tiedje JM, Cole JR. 2007. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Applied and Environmental Microbiology 73:5261-5267 DOI 10.1128/AEM.00062-07
57. Weglarz L, Dzierzewicz Z, Skop B, Orchel A, Parfiniewicz B, Wisniowska B, Swiatkowska L, Wilczok T. 2003. Desulfovibrio desulfuricans lipopolysaccharides induce endothelial cell IL-6 and IL-8 secretion and E-selectin and VCAM-1 expres-sion. Cellular & Molecular Biology Letters 8:991-1003
58. Weitkunat K, Schumann S, Petzke KJ, Blaut M, Loh G, Klaus S. 2015. Effects of dietary inulin on bacterial growth, short-chain fatty acid production and hepatic lipid metabolism in gnotobiotic mice. Journal of Nutritional Biochemistry 26:929-937 DOI 10.1016/j.jnutbio.2015.03.010
59. Wu X, Ma C, Han L, Nawaz M, Gao F, Zhang X, Yu P, Zhao C, Li L, Zhou A, Wang J, Moore JE, Millar BC, Xu J. 2010. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Current Microbiology 61:69-78 DOI 10.1007/s00284-010-9582-9
60. Xie G, Wang X, Liu P, Wei R, Chen W, Rajani C, Hernandez BY, Alegado R, Dong B, Li D, Jia W. 2016. Distinctly altered gut microbiota in the progression of liver disease. Oncotarget 7:19355-19366 DOI 10.18632/oncotarget.8466
61. Yan X, Feng B, Li P, Tang Z, Wang L. 2016. Microflora disturbance during progression of glucose intolerance and effect of sitagliptin: an animal study. Journal of Diabetes Research 2016:Article 2093171 DOI 10.1155/2016/2093171
62. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, Mao Y, Zhang X, Pang X, Wei C, Zhao G, Chen Y, Zhao L. 2010. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME Journal 4:232-241 DOI 10.1038/ismej.2009.112
63. Zhang Q, Sun X, Xiao X, Zheng J, Li M, Yu M, Ping F, Wang Z, Qi C, Wang T, Wang X. 2016. Maternal chromium restriction leads to glucose metabolism imbalance in mice offspring through insulin signaling and wnt signaling pathways. International Journal of Molecular Sciences 17:E1767 DOI 10.3390/ijms17101767
64. Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L. 2013. Human gut microbiota changes reveal the progression of glucose intolerance. PLOS ONE 8:e71108 DOI 10.1371/journal.pone.0071108
65. Zhang X, Zhao Y, Xu J, Xue Z, Zhang M, Pang X, Zhang X, Zhao L. 2015. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Scientific Reports 5:14405 DOI 10.1038/srep14405
66. Zhu Y, Bai J, Zhang Y, Xiao X, Dong Y. 2016. Effects of bitter melon (Momordica charantia L.) on the gut microbiota in high fat diet and low dose streptozocin-induced rats. International Journal of Food Sciences and Nutrition 67:686-695 DOI 10.1080/09637486.2016.1197185